These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17375078)

  • 21. Glucose tolerance and insulin resistance in the JCR:LA-corpulent rat: effect of miglitol (Bay m1099).
    Russell JC; Graham SE; Dolphin PJ
    Metabolism; 1999 Jun; 48(6):701-6. PubMed ID: 10381143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic dietary n-3 PUFA intervention improves dyslipidaemia and subsequent cardiovascular complications in the JCR:LA- cp rat model of the metabolic syndrome.
    Lu J; Borthwick F; Hassanali Z; Wang Y; Mangat R; Ruth M; Shi D; Jaeschke A; Russell JC; Field CJ; Proctor SD; Vine DF
    Br J Nutr; 2011 Jun; 105(11):1572-82. PubMed ID: 21276281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MR molecular imaging of aortic angiogenesis.
    Cai K; Caruthers SD; Huang W; Williams TA; Zhang H; Wickline SA; Lanza GM; Winter PM
    JACC Cardiovasc Imaging; 2010 Aug; 3(8):824-32. PubMed ID: 20705262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sustained decreases in weight and serum insulin, glucose, triacylglycerol and cholesterol in JCR:LA-corpulent rats treated with D-fenfluramine.
    Brindley DN; Hales P; al-Sieni AI; Russell JC
    Br J Pharmacol; 1992 Mar; 105(3):679-85. PubMed ID: 1628154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular response to angiotensin II in upper body obesity.
    Nielsen S; Halliwill JR; Joyner MJ; Jensen MD
    Hypertension; 2004 Oct; 44(4):435-41. PubMed ID: 15337733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulation of hypothalamic pro-opiomelanocortin (POMC) expression after weaning is associated with hyperphagia-induced obesity in JCR rats overexpressing neuropeptide Y.
    Diané A; Pierce WD; Russell JC; Heth CD; Vine DF; Richard D; Proctor SD
    Br J Nutr; 2014 Mar; 111(5):924-32. PubMed ID: 24094067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonged REM sleep restriction induces metabolic syndrome-related changes: Mediation by pro-inflammatory cytokines.
    Venancio DP; Suchecki D
    Brain Behav Immun; 2015 Jul; 47():109-17. PubMed ID: 25532784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pioglitazone improves superoxide dismutase mediated vascular reactivity in the obese Zucker rat.
    Dorafshar AH; Moodley K; Khoe M; Lyon C; Bryer-Ash M
    Diab Vasc Dis Res; 2010 Jan; 7(1):20-7. PubMed ID: 20368229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-intensity voluntary running lowers blood pressure with simultaneous improvement in endothelium-dependent vasodilatation and insulin sensitivity in aged spontaneously hypertensive rats.
    Sun MW; Qian FL; Wang J; Tao T; Guo J; Wang L; Lu AY; Chen H
    Hypertens Res; 2008 Mar; 31(3):543-52. PubMed ID: 18497475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of benfluorex on serum triacylglycerols and insulin sensitivity in the corpulent rat.
    Russell JC; Graham SE; Dolphin PJ; Brindley DN
    Can J Physiol Pharmacol; 1996 Aug; 74(8):879-86. PubMed ID: 8960376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiatherogenic effects of long-term benfluorex treatment in male insulin resistant JCR:LA-cp rats.
    Russell JC; Graham SE; Dolphin PJ; Amy RM; Wood GO; Brindley DN
    Atherosclerosis; 1997 Jul; 132(2):187-97. PubMed ID: 9242964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic insulin gene therapy prevents deterioration of vascular function and improves adipocytokine profile in STZ-diabetic rats.
    Thulé PM; Campbell AG; Kleinhenz DJ; Olson DE; Boutwell JJ; Sutliff RL; Hart CM
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E114-E122. PubMed ID: 16118252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intermittent fasting and dietary supplementation with 2-deoxy-D-glucose improve functional and metabolic cardiovascular risk factors in rats.
    Wan R; Camandola S; Mattson MP
    FASEB J; 2003 Jun; 17(9):1133-4. PubMed ID: 12709404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired postprandial apolipoprotein-B48 metabolism in the obese, insulin-resistant JCR:LA-cp rat: increased atherogenicity for the metabolic syndrome.
    Vine DF; Takechi R; Russell JC; Proctor SD
    Atherosclerosis; 2007 Feb; 190(2):282-90. PubMed ID: 16624317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormal insulin and glucose metabolism in the JCR:LA-corpulent rat.
    Russell JC; Graham S; Hameed M
    Metabolism; 1994 May; 43(5):538-43. PubMed ID: 8177040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Astaxanthin ameliorates features of metabolic syndrome in SHR/NDmcr-cp.
    Hussein G; Nakagawa T; Goto H; Shimada Y; Matsumoto K; Sankawa U; Watanabe H
    Life Sci; 2007 Jan; 80(6):522-9. PubMed ID: 17074368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delayed insulin transport across endothelium in insulin-resistant JCR:LA-cp rats.
    Wascher TC; Wölkart G; Russell JC; Brunner F
    Diabetes; 2000 May; 49(5):803-9. PubMed ID: 10905490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disturbances in nitric oxide/cyclic guanosine monophosphate system in SHR/NDmcr-cp rats, a model of metabolic syndrome.
    Kagota S; Yamaguchi Y; Tanaka N; Kubota Y; Kobayashi K; Nejime N; Nakamura K; Kunitomo M; Shinozuka K
    Life Sci; 2006 Feb; 78(11):1187-96. PubMed ID: 16188278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telmisartan provides protection against development of impaired vasodilation independently of metabolic effects in SHRSP.Z-Lepr(fa)/IzmDmcr rats with metabolic syndrome.
    Kagota S; Tada Y; Nejime N; Nakamura K; Kunitomo M; Shinozuka K
    Can J Physiol Pharmacol; 2011 May; 89(5):355-64. PubMed ID: 21619437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A unique rodent model of cardiometabolic risk associated with the metabolic syndrome and polycystic ovary syndrome.
    Shi D; Dyck MK; Uwiera RR; Russell JC; Proctor SD; Vine DF
    Endocrinology; 2009 Sep; 150(9):4425-36. PubMed ID: 19470707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.